Veranex brings together best-in-class expertise in product design and engineering, medical device evaluation, clinical development, data management, regulatory, and market access to deliver an integrated and comprehensive solution from concept to commercial success. Headquartered in Paris, Veranex Preclincal Services, France (formerly known as IMMR) is a world-class, market leader in the design and conduct of MedTech and Biotech preclinical studies in large models. Its in-house expertise and state-of-the-art, FDA, OECD GLP-inspected and AAALAC International-accredited facilities are unparalleled for successfully completing sophisticated studies with novel interventional or surgical technologies. While we are perhaps most well-known for our world-leading expertise in complex cardiovascular procedures, we also have broad experience and capabilities across multiple non-cardiovascular disease areas (neurostimulation, gastroenterology, ophthalmology, thoracic surgery, orthopedics, urology, fetal surgery, ophthalmology and robotics). Our unique, highly efficient and full-service approach saves money and reduces time to market with studies that are carefully planned, expertly conducted to the highest ethical standards and professionally documented. We excel in procedures ranging from early feasibility studies through to GLP studies to support worldwide regulatory approvals. Our team can ensure low procedural and post-procedural complications and high success rates thanks to: - Direct oversight and performance of procedures by experienced veterinary surgeons - Our team of professionals with more than 30 years of shared experience - A team that has demonstrated success partnering with more than 80 clients from 15 countries over the last 2 years - A state-of-the-art facility with 5 operating rooms including 2 hybrid ORs, endoscopy and videoscopy towers, cardiopulmonary bypass machines and sophisticated imaging including CT and intracardiac ultrasound - & much more